ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2533

Weight Loss Is Associated with Structure Modification in Subjects with Radiographic Osteoarthritis of the Knee: Data From the Osteoarthritis Initiative

Marc C. Hochberg1, Danuta I. Bujak2, Jeffrey W. Duryea3, Knachelle Favors4 and John D. Sorkin4, 1Department of Medicine, University of Maryland, Baltimore, MD, 2School of Medicine, University of Maryland, Baltimore, MD, 3Dept of Radiology, Brigham & Women, Boston, MA, 4VA Maryland Health Care System, Baltimore, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, obesity and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Weight, Activity, and Metabolic Effects on Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Obesity is a risk factor for the development and progression of knee osteoarthritis (OA) and weight loss is recommended as part of the management of patients with knee OA. We tested the hypothesis that weight loss is associated with structural progression, as measured by the rate of decline in joint space width (JSW), in subjects with radiographic knee OA.

Methods:

Data for this analysis were obtained from the Osteoarthritis Initiative (OAI) public access database (http://www.oai.ucsf.edu). At each visit, subjects completed an extensive battery of questionnaires; weight was measured with a balance beam scale; and fixed flexion, weight-bearing PA radiographs of both knees were obtained using a standard protocol and the Synaflexer platform. We examined data from the baseline, 12-, 24-, 36- and 48-month follow-up visits for subjects with radiographic knee OA. Medial compartment JSW was determined using digitized images and a software tool; all images from a subject were analyzed together blinded to time sequence (see http://oai.epi-ucsf.org/datarelease/SASDocs/kXR_QJSW_Duryea_descrip.pdf for documentation). Mean change in both minimum (mJSW) and JSW0.25 were examined using multiple variable random effects (random slope and random intercept) models including weight, age, WOMAC pain score and use of analgesic and/or anti-inflammatory medications at each visit along with sex, race/ethnicity, and study site from baseline.

Results:

Data from 2683 subjects with radiographic OA in one or both knees (Kellgren-Lawrence grade >=2 on baseline radiograph), with measurement of mJSW and JSW0.25 at one or more time points (median = 3) were included in the analysis. If both knees were affected by radiographic OA, data for the right knee were arbitrarily used in the analysis. Mean (SD) age was 62.1 (9.1) years, weight was 83.9 (16.0) kg, mJSW was 3.97 (1.46) mm and JSW0.25 was 5.36 (1.54) mm at baseline. The mean rate of decline in JSW was more rapid for JSW0.25 than mJSW (0.110 [0.0055] mm vs. 0.088 [0.0055] mm; difference = 0.021 mm/year [95% CI 0.006, 0.037], P = 0.006). Heavier weight was significantly associated with narrower joint space at both mJSW and JSW0.25 at all visits (P < 0.0001). There was a significant inverse association between change in weight and change in both mJSW and JSW0,25 in the multiple variable adjusted models such that subjects with a decline in weight over time had a smaller adjusted rate of decline in both mJSW and JSW0.25 that those who had an increase in weight.  The rate of decline in JSW per unit change in weight did not differ, however, for JSW0.25 and mJSW. Sensitivity analyses performed after excluding subjects with isolated lateral compartment disease (OARSI medial compartment JSN grade = 0 and lateral compartment JSN grade >=1) did not alter the results. Finally, higher WOMAC pain scores and use of analgesic and/or anti-inflammatory medications were both independently associated with the rate of decline in JSW in multiple variable models.

Conclusion:

These data demonstrate an association between weight loss and a reduction in the rate of decline in both mJSW and JSW0.25 in subjects with radiographic knee OA. Weight loss should be recommended as an approach for both symptom and structure modification in knee OA.


Disclosure:

M. C. Hochberg,

Abbott Laboratories, Astra-Zeneca, Bioiberica S.A., Eli Lilly Inc., Genentech/Roche, Merck Inc., Novartis Pharma A.G., Pfizer Inc., Stryker LLC, Xoma.,

5;

D. I. Bujak,
None;

J. W. Duryea,
None;

K. Favors,
None;

J. D. Sorkin,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/weight-loss-is-associated-with-structure-modification-in-subjects-with-radiographic-osteoarthritis-of-the-knee-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology